Drug warnings to doctors
David Jay Dearinger, Sr., et ux. v. Eli Lilly and
In brief
- Where it stands
- Dismissed
Petition denied.
- What it’s about
- David and Ganna Dearinger asked the Supreme Court to review their case against Eli Lilly, raising whether the rule that drug warnings may go through doctors rather than directly to patients (the learned intermediary doctrine) violates due process and whether lower courts misapplied a federal law on requesting lawyers for people who cannot afford one.
- Who it affects
- The Dearingers’ request for Supreme Court review is over, but the order does not resolve either legal question.
Summary: written with AI from the case record.
What it's about
The Court refused to hear the case (denied review) and did not decide either question.
The dispute raised whether drugmakers may direct warnings to doctors instead of patients and whether lower courts misapplied a federal law about requesting a lawyer for someone unable to afford one.
Question presented
1. Does the Learned Intermediary Doctrine, Which the Supreme Court Has Not Yet Examined, Violate Due Process? 2. Should the Supreme Court Reexamine Its Decision in Mallard v. United States Dist. Court for Southern Dist. of Iowa, 490 U.S. 296 (1989) Because of the Lower Courts’ Misapplication of 28 U.S.C. § 1915(e)(1)?
Documents
Docket activity
New analysis added
AI analysis generated: Case Briefing
AI analysis generated: Decision Record
Case data updated: summary, question_presented, generation_metadata
Case data updated: question_presented, extraction_metadata
Show 1 moreShow fewer
Brief added: Petition
Sources
Primary materials plus reporting. Best-effort analysis: this explainer relies on a mix of primary materials and trusted secondary sources. Official filings and opinions remain authoritative.